Unmasking the Medications You Shouldn’t Be Paying For

Hundreds of prescription medications process every day and patients and plan sponsors pay for them because that's what...

Read More

NASH: The growing and costly disease you probably don’t know about but should

Nonalcoholic steatohepatitis (NASH) is a type of nonalcoholic fatty liver disease (NAFLD). Like its name states, NASH...

Read More

Updates to Biologics, COVID-19 and Medicare Part D: What You Need to Know

Spring has sprung and so have the announcements from Centers for Medicare and Medicaid Services (CMS). The month of...

Read More

The Speed and Accuracy of Mail Order with the Personal Care Members Need

When the pandemic hit, people learned new ways to work, shop and communicate. They also switched to mail order pharmacy...

Read More

The Inflation Reduction Act Kicks Off Big Changes to Medicare Prescription Coverage

The Inflation Reduction Act (IRA) was signed into law in August 2022 and went into effect January 1, 2023. The IRA...

Read More

Four Strategies to Successfully Manage Specialty Medications

While specialty medications provide a new level of hope for people being treated for serious conditions such as...

Read More

Five Pipeline Developments to Watch in 2023

From biosimilars and COVID-19 to gene therapy and microbiomes, there are several developments in the pipeline to watch...

Read More

Looking Ahead to 2023: Medicare Readiness

The 2022 audit cycle is coming to a close. CMS issued its last engagement letters for 2022 program audits at the end of...

Read More

New Guidelines for Diabetes First Line Therapy Could Lead to Increases in Drug Spend

Diabetes is an epidemic that drives a significant amount of medical cost. Eleven percent of the United States’...

Read More

Elixir’s 2023 Formularies Drive Optimal Value with Under 1% Member Disruption

At Elixir, whole member health is at the heart of our formulary strategy and drug management practices. As we prepare...

Read More